Inactive Instrument
Precision Therapeutics Inc Stock Nasdaq
Stocks
US74033P1003
Biotechnology & Medical Research
| Market Cap | 71.27M 62.6M 58.21M 53.42M 100M 6.86B 102M 691M 270M 3.37B 268M 262M 11.67B | P/E 2024 |
-0.35x | P/E 2025 | -0.53x |
|---|---|---|---|---|---|
| Enterprise Value | 62.15M 54.58M 50.76M 46.58M 87.52M 5.98B 88.87M 603M 236M 2.94B 233M 228M 10.17B | EV / Sales 2024 |
4.23x | EV / Sales 2025 | 121x |
| Free-Float |
93.75% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Precision Therapeutics Inc
| 1 day | -7.56% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 09/02/2026 | |
| Director of Finance/CFO | - | 16/04/2026 | |
Kyle Okamoto
PSD | President | - | 01/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Handley
BRD | Director/Board Member | 66 | 19/02/2020 |
Charles L. Nuzum
CHM | Chairman | 78 | 09/02/2026 |
| Director/Board Member | 60 | 09/07/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -7.56% | -8.33% | - | - | 71.27M | ||
| +1.07% | -3.49% | -3.35% | +10.44% | 46.86B | ||
| +0.25% | +1.65% | +399.22% | +634.87% | 40.23B | ||
| -0.27% | +4.45% | +11.81% | +65.64% | 36.23B | ||
| +0.35% | +0.87% | +4.46% | -10.16% | 34.72B | ||
| +3.14% | +1.02% | +4.76% | +40.92% | 27.89B | ||
| -0.73% | +11.84% | +34.39% | +134.36% | 16.79B | ||
| +0.47% | -2.74% | - | - | 16.74B | ||
| +0.42% | -5.52% | -3.43% | +9.03% | 13.12B | ||
| -2.68% | -2.49% | -11.36% | -33.61% | 12.7B | ||
| Average | -0.55% | +0.83% | +54.56% | +106.44% | 27.25B | |
| Weighted average by Cap. | +0.48% | +0.91% | +74.42% | +136.27% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.62M 1.43M 1.33M 1.22M 2.29M 156M 2.32M 15.75M 6.15M 76.88M 6.1M 5.96M 266M | 125K 110K 102K 93.9K 176K 12.06M 179K 1.22M 475K 5.93M 470K 460K 20.51M |
| Net income | -12.66M -11.12M -10.34M -9.49M -17.84M -1.22B -18.11M -123M -47.99M -600M -47.54M -46.52M -2.07B | -233M -205M -190M -175M -328M -22.45B -333M -2.26B -883M -11.04B -875M -856M -38.16B |
| Net Debt | 1.4M 1.23M 1.14M 1.05M 1.97M 134M 2M 13.54M 5.29M 66.11M 5.24M 5.13M 229M | -9.12M -8.01M -7.45M -6.84M -12.85M -879M -13.05M -88.5M -34.58M -432M -34.25M -33.52M -1.49B |
Employees
-

















